Skip to main content
Caplight Logo









AIM7

AIM7

Private
Houston, TexasHealthcare & Life Scienceshttps://aim7.com

Last Round

Seed

Dec 19, 2022

Total Funding Raised

$1.3M

Company Overview

AIM7 operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Seed round in December 2022.

AIM7 is a health and wellness technology company that provides an AI-powered data integration platform for personalized fitness, recovery, and performance recommendations.

Sector

Healthcare & Life Sciences

Verticals

Sports & Fitness, Health IoT, Personalization, Sports Analytics

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

AIM7 Comparables

Compare AIM7 with similar companies based on industry and business-model similarity.

AIM7 comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Athlytic
88%
Vora AI Inc.
87%
Bevel
86%
Book a demo to see all comparables

For institutional investors. Book with your work email.

AIM7 Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 19, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Erik Korem

Founder CEO at AIM7

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 23, 2026

    Monthly visitors increased 48% MoM.

  • Mar 3, 2026

    Monthly visitors increased 35% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

AIM7 Filings

Explore SEC and related filing metadata, where available.

AIM7 filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about AIM7's valuation, stock price, and market status.

Is AIM7 a public or private company?

AIM7 is a private company.

What is the current stock price of AIM7?

AIM7 is a private company, so its shares have no public market price. Caplight tracks AIM7's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is AIM7 worth (valuation)?

Valuation information for AIM7 is not publicly available.

Can I buy AIM7 stock?

AIM7 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was AIM7's last funding round?

AIM7's most recent funding round was Seed on December 19, 2022.

Who are the main investors in AIM7?

Investor information for AIM7 is not publicly disclosed.

Will AIM7 IPO soon?

No public IPO plans have been announced for AIM7.

How can I track AIM7 secondary market activity?

Caplight tracks bids, offers, and trades in AIM7's shares on secondary markets.

Firmographic Details

HeadquartersHouston, Texas
Employee Range11
Year Founded2020
Last FundingDec 19, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?